Deciphera Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Deciphera Pharmaceuticals, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $24.96 per share as of 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2024-02-07
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $24.96.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $26.51.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $29.06.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $20.60.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2023-12-31 | $24.96 10-K · filed 2024-02-07 |
| 2022-12-31 | $26.51 10-K · filed 2023-02-07 |
| 2021-12-31 | $29.06 10-K · filed 2022-02-08 |
| 2020-12-31 | $20.60 10-K · filed 2021-02-09 |
| 2019-12-31 | $10.62 10-K · filed 2020-03-09 |
| 2018-12-31 | $5.20 10-K · filed 2019-03-14 |
| 2017-12-31 | $3.21 10-K · filed 2018-03-28 |